Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-23

Clinical Trial Update: Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility [Phase 3]

View source ↗

Summary

Phase 3 trial investigating liraglutide with metformin for weight loss and metabolic/endocrine parameters in women with PCOS, obesity, and infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)
  • metformin (metformin)

Snippet

Sponsor: Mỹ Đức Hospital | Conditions: Polycystic Ovary Syndrome, Obesity | Phase 3 | Status: UNKNOWN